I. Sharif

Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemia-reperfusion injury

G. Gray, Helen L Jeanes, P. Wanikiat, 2006, Menopause.

Human urotensin II increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition.

G. Gray, I. Sharif, M. Jones, 2001, Life sciences.

The effects of endothelin-1 on ischaemia-induced ventricular arrhythmias in rat isolated hearts.

C. Wainwright, K. Kane, I. Sharif, 2001, European journal of pharmacology.

Influence of scanning frequency and ultrasonic contrast agent on reproducibility of left ventricular measurements in the mouse.

D. Webb, W. McDicken, T. Anderson, 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Explorer Deficiency of PDK 1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia

C. Kahn, D. Alessi, L. Bertrand, 2017 .

Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia

D. Alessi, L. Bertrand, A. Mora, 2003, The EMBO journal.

Targeting C-reactive protein for the treatment of cardiovascular disease

Steven V. Ley, Carol V. Robinson, Darren Thompson, 2006, Nature.

Oestrogen and the cardiovascular system: the good, the bad and the puzzling.

D. Webb, J. Seckl, G. Gray, 2001, Trends in pharmacological sciences.

Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis.

B. Walker, A. Dover, G. Small, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?

C. Wainwright, K. Kane, I. Sharif, 1998, Cardiovascular research.